At a glance
- Originator Procter & Gamble
- Class
- Mechanism of Action Geranylgeranyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 19 Feb 2002 Preclinical development for Postmenopausal osteoporosis in USA (PO)